Sarepta Therapeutics Inc (SRPT)

Working capital turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	1,901,979	1,640,348	1,504,993	1,403,300	1,243,336	1,104,982	1,003,434	975,683	933,013	876,047	835,184	765,786	701,887	645,564	600,082	573,356	540,099	495,074	450,191	407,496
Total current assets	US$ in thousands	3,073,460	2,685,370	2,683,640	2,464,860	2,579,330	2,450,850	2,472,610	2,488,380	2,557,860	2,625,930	2,469,300	2,530,950	2,604,100	2,185,310	2,265,220	2,271,350	2,485,200	2,322,670	2,459,420	2,547,350
Total current liabilities	US$ in thousands	731,684	699,489	688,490	608,709	653,659	450,743	498,654	536,884	619,604	602,916	545,566	454,962	452,733	373,443	425,022	364,736	416,026	378,388	354,896	306,429
Working capital turnover		0.81	0.83	0.75	0.76	0.65	0.55	0.51	0.50	0.48	0.43	0.43	0.37	0.33	0.36	0.33	0.30	0.26	0.25	0.21	0.18

December 31, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $1,901,979K ÷ ($3,073,460K – $731,684K)
= 0.81

The working capital turnover ratio of Sarepta Therapeutics Inc has shown a positive trend over the analyzed period, increasing steadily from 0.18 on March 31, 2020, to 0.81 on December 31, 2024. This indicates that the company has been utilizing its working capital more efficiently to generate revenue. The uptrend in the ratio suggests that Sarepta Therapeutics has been improving its ability to convert working capital into sales.

The ratio reached its lowest point at 0.18 on March 31, 2020, and has since exhibited consistent growth, peaking at 0.83 on September 30, 2024, showcasing the company's enhanced efficiency in managing its working capital over time.

Overall, the upward trend in Sarepta Therapeutics' working capital turnover ratio reflects the company's improved operational efficiency and effectiveness in utilizing its working capital resources to drive revenue growth.